Question 1

What are the potential benefits of adding sunitinib to my FOLFIRI treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the FOLFIRI and Sunitinib in Metastatic Colorectal Cancer clinical trial (NCT00806663). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this trial affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the FOLFIRI and Sunitinib in Metastatic Colorectal Cancer clinical trial (NCT00806663). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from sunitinib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the FOLFIRI and Sunitinib in Metastatic Colorectal Cancer clinical trial (NCT00806663). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the FOLFIRI and Sunitinib in Metastatic Colorectal Cancer clinical trial (NCT00806663). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests will be done to monitor my progress?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the FOLFIRI and Sunitinib in Metastatic Colorectal Cancer clinical trial (NCT00806663). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks or concerns I should be aware of before participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the FOLFIRI and Sunitinib in Metastatic Colorectal Cancer clinical trial (NCT00806663). Contact the study team or your healthcare provider for specific answers.

What this study is about